Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
HepVu Map on Hep C, Opioids
New data on Hepatitis C and other health indicators are available on HepVu.News Article updated on 03/08/2024 -
Best Practices Compilation Continues to Grow
The Best Practices Compilation of tested HIV care interventions has added a new set of project innovations.Blog updated 07/15/2024
-
Is Medicare About to Cover PrEP Under Part B?
Is Medicare going to adopt the practice of private health insurance and start covering PrEP without cost-sharing under Part B?News Article updated on 05/14/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Hepatitis Rates Improve Across the Board: CDC Surveillance Report
Rates of hepatitis, across the ABC alphabet, have declined in recent years, according to the 2022 Viral Hepatitis Surveillance Report (CDC, April 2024).News Article updated on 04/09/2024 -
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
PrEP Policies and Programs Help End the HIV Epidemic
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
-
Toolkit Features State Strategies to Improve the Health of People with HIV
HHS has supported development of a toolkit on state Medicaid and health department coordination to improve HIV care delivery.
Blog updated 12/28/2022
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
Evidence-Informed Interventions in Four HIV Care Continuum Manuals
Evidence-informed interventions for engaging persons with HIV in care (incarceration/community release; buprenorphine; patient navigation for women of color; peer linkages for women of color).
Blog updated 01/07/2021
-
Few Get Needed Opioid Use Disorder Treatments
Only a small percentage of people in the U.S. with opioid use disorder (OUD) are receiving needed treatments.News Article updated on 07/18/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
OI Guidelines Update on Anal Cancer Screening
A panel of experts in HIV care has released new recommendations to prevent anal cancer for people with HIV, the first U.S. federal guidelines on the topic.News Article updated on 07/11/2024 -
Program Letter: Role of RWHAP in Addressing STIs and Mpox
State AIDS Drug Assistance Programs (ADAPs), which provide medications for people with HIV who lack health coverage. play "a critical role in addressing STIs for people with HIV"News Article updated on 05/24/2023 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
Mpox Emergency is Over
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023